Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Mar 28, 2024

SELL
$0.35 - $0.53 $210 - $318
-600 Reduced 13.04%
4,000 $2,000
Q3 2023

Oct 17, 2023

SELL
$0.38 - $0.58 $532 - $812
-1,400 Reduced 23.33%
4,600 $1,000
Q1 2021

Sep 07, 2021

BUY
$8.81 - $16.96 $52,860 - $101,760
6,000 New
6,000 $56,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $1.41B
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.